Our services

Drug repositioning

Indication expansion of existing and newly developed drug
(Drug repositioning)

Evaluating newly developed drug for positioning in new disease areas/patient strata to increase its value and lower risk of project failure?
Evaluating existing drug for positioning into rare/orphan indication to gain market exclusivity and expand market size and profitability?


Our exhaustive biomarker profiling of the drug and intended indications coupled with our unique fish-net approach enables the quantification of relative relevance of the drug to effective treatment response in other indications.

Recommendations of potential disease areas/patient groups for expansion including justifications based on clients’ requirement can be provided.

Impact & Benefits

Expansion of the clients’ portfolio with a market differentiating drug product showing superior efficacy in different indications/patient groups especially in combination therapy approaches

Preserving value of the client's novel molecule via clinical rescue

Value addition to shelved clinical trial assets

Market exclusivity via 505(b)(2) regulatory pathway

Schedule a free exploratory call to find out more
Contact us